Registered entities
Poseida Therapeutics, Inc.
Reg. No. 472846548United States
Innovation
74 patent families (23 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 14,638 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 24 |
| 2020 | 18 |
| 2021 | 20 |
| 2022 | 16 |
| 2023 | 18 |
| 2024 | 32 |
| 2025 | 32 |
| 2026 | 20 |
Investor mix
14 investors on record; lead investors include Novartis, Longitude Capital, Fidelity Investments; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 29% |
| Private equity | 5 | 36% |
| Angel & family office | 1 | 7% |
| Other / undisclosed | 4 | 29% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
5 Nov 2025 · CONTRACTOR - Environmental Health and Safety Engineer · San Diego
23 Sep 2025 · Validation Engineer II · San Diego
23 Aug 2025 · CONTRACTOR - Facilities Technician · San Diego
23 Aug 2025 · CONTRACTOR - Facilities Engineering Technician · San Diego
15 Dec 2024 · Director/Sr Director, Clinical Sciences · Las Vegas
Based on job postings tracked across public sources.